{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T11:43:50Z","timestamp":1791546230871,"version":"4.3.4"},"reference-count":123,"publisher":"MDPI AG","issue":"1","license":[{"start":{"date-parts":[[2019,12,28]],"date-time":"2019-12-28T00:00:00Z","timestamp":1577491200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100008273","name":"Novartis Foundation","doi-asserted-by":"publisher","award":["19B116"],"award-info":[{"award-number":["19B116"]}],"id":[{"id":"10.13039\/100008273","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Viruses"],"abstract":"<jats:p>Human cytomegalovirus (HCMV) infects more than 70% of the human population worldwide. HCMV is responsible for high morbidity and mortality in immunocompromised patients and remains the leading viral cause of congenital birth defects. Despite considerable efforts in vaccine and therapeutic development, HCMV infection still represents an unmet clinical need and a life-threatening disease in immunocompromised individuals and newborns. Immune repertoire interrogation of HCMV seropositive patients allowed the identification of several potential antigens for vaccine design. However, recent HCMV vaccine clinical trials did not lead to a satisfactory outcome in term of efficacy. Therefore, combining antigens with orthogonal technologies to further increase the induction of neutralizing antibodies could improve the likelihood of a vaccine to reach protective efficacy in humans. Indeed, presentation of multiple copies of an antigen in a repetitive array is known to drive a more robust humoral immune response than its soluble counterpart. Virus-like particles (VLPs) and nanoparticles (NPs) are powerful platforms for multivalent antigen presentation. Several self-assembling proteins have been successfully used as scaffolds to present complex glycoprotein antigens on their surface. In this review, we describe some key aspects of the immune response to HCMV and discuss the scaffolds that were successfully used to increase vaccine efficacy against viruses with unmet medical need.<\/jats:p>","DOI":"10.3390\/v12010035","type":"journal-article","created":{"date-parts":[[2019,12,30]],"date-time":"2019-12-30T05:49:41Z","timestamp":1577684981000},"page":"35","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":38,"title":["Virus-Like Particles and Nanoparticles for Vaccine Development against HCMV"],"prefix":"10.3390","volume":"12","author":[{"given":"Michela","family":"Perotti","sequence":"first","affiliation":[{"name":"Faculty of Biomedical Sciences, Institute for Research in Biomedicine, Universit\u00e0 della Svizzera Italiana, 6500 Bellinzona, Switzerland"},{"name":"Institute of Microbiology, ETH Z\u00fcrich, 8093 Z\u00fcrich, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8860-7928","authenticated-orcid":false,"given":"Laurent","family":"Perez","sequence":"additional","affiliation":[{"name":"Faculty of Biomedical Sciences, Institute for Research in Biomedicine, Universit\u00e0 della Svizzera Italiana, 6500 Bellinzona, Switzerland"},{"name":"European Virus Bioinformatics Center, 07743 Jena, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2019,12,28]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1002\/rmv.535","article-title":"Review and meta-analysis of the epidemiology of congenital cytomegalovirus (CMV) infection","volume":"17","author":"Kenneson","year":"2007","journal-title":"Rev. Med. Virol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"7437","DOI":"10.1016\/j.vaccine.2018.02.089","article-title":"Vaccination against the human cytomegalovirus","volume":"37","author":"Plotkin","year":"2018","journal-title":"Vaccine"},{"key":"ref_3","first-page":"417","article-title":"Manifestations of human cytomegalovirus infection: Proposed mechanisms of acute and chronic disease","volume":"325","author":"Britt","year":"2008","journal-title":"Curr. Top. Microbiol. Immunol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1002\/(SICI)1096-9071(199805)55:1<64::AID-JMV11>3.0.CO;2-#","article-title":"Circulating cytomegalic endothelial cells are associated with high human cytomegalovirus (HCMV) load in AIDS patients with late-stage disseminated HCMV disease","volume":"55","author":"Gerna","year":"1998","journal-title":"J. Med. Virol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.2217\/imt-2015-0028","article-title":"Strategies to control human cytomegalovirus infection in adult hematopoietic stem cell transplant recipients","volume":"8","author":"Lilleri","year":"2016","journal-title":"Immunotherapy"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1093\/infdis\/171.5.1115","article-title":"Antiviral antibody responses and intrauterine transmission after primary maternal cytomegalovirus infection","volume":"171","author":"Boppana","year":"1995","journal-title":"J. Infect. Dis."},{"key":"ref_7","first-page":"2544","article-title":"Hyperimmune globulin to prevent congenital CMV infection","volume":"370","author":"Spinillo","year":"2014","journal-title":"N. Engl. J. Med."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1097\/MOP.0000000000000305","article-title":"Advances in the prevention and treatment of congenital cytomegalovirus infection","volume":"28","author":"James","year":"2016","journal-title":"Curr. Opin. Pediatrics"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1186\/s13052-017-0358-8","article-title":"Congenital Cytomegalovirus infection: Advances and challenges in diagnosis, prevention and treatment","volume":"43","author":"Marsico","year":"2017","journal-title":"Ital. J. Pediatrics"},{"key":"ref_10","doi-asserted-by":"crossref","unstructured":"Gomes, A.C., Griffiths, P.D., and Reeves, M.B. (2019). The Humoral Immune Response Against the gB Vaccine: Lessons Learnt from Protection in Solid Organ Transplantation. Vaccines, 7.","DOI":"10.3390\/vaccines7030067"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"6110","DOI":"10.1073\/pnas.1806420115","article-title":"Recombinant cytomegalovirus glycoprotein B vaccine: Rethinking the immunological basis of protection","volume":"115","author":"Schleiss","year":"2018","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1038\/s41541-018-0074-4","article-title":"A new era in cytomegalovirus vaccinology: Considerations for rational design of next-generation vaccines to prevent congenital cytomegalovirus infection","volume":"3","author":"Nelson","year":"2018","journal-title":"Npj Vaccines"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.3389\/fmicb.2019.01005","article-title":"HCMV Envelope Glycoprotein Diversity Demystified","volume":"10","author":"Foglierini","year":"2019","journal-title":"Front. Microbiol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"6267","DOI":"10.1073\/pnas.1800177115","article-title":"HCMV glycoprotein B subunit vaccine efficacy mediated by nonneutralizing antibody effector functions","volume":"115","author":"Nelson","year":"2018","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"6273","DOI":"10.1073\/pnas.1800224115","article-title":"Protection from cytomegalovirus viremia following glycoprotein B vaccination is not dependent on neutralizing antibodies","volume":"115","author":"Baraniak","year":"2018","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.ebiom.2019.11.005","article-title":"Seronegative patients vaccinated with cytomegalovirus gB-MF59 vaccine have evidence of neutralising antibody responses against gB early post-transplantation","volume":"50","author":"Baraniak","year":"2019","journal-title":"EBioMedicine"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1099\/vir.0.070441-0","article-title":"Differential kinetics of human cytomegalovirus load and antibody responses in primary infection of the immunocompetent and immunocompromised host","volume":"96","author":"Gerna","year":"2015","journal-title":"J. Gen. Virol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"352","DOI":"10.3389\/fimmu.2016.00352","article-title":"CMV-Specific CD8 T Cell Differentiation and Localization: Implications for Adoptive Therapies","volume":"7","author":"Smith","year":"2016","journal-title":"Front. Immunol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"1916","DOI":"10.1093\/infdis\/jiw487","article-title":"Maternal Antibody Responses and Nonprimary Congenital Cytomegalovirus Infection of HIV-1-Exposed Infants","volume":"214","author":"Bialas","year":"2016","journal-title":"J. Infect. Dis."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"S73","DOI":"10.1016\/j.placenta.2017.04.011","article-title":"Maternal immune correlates of protection against placental transmission of cytomegalovirus","volume":"60","author":"Itell","year":"2017","journal-title":"Placenta"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.3389\/fmicb.2019.01186","article-title":"Human Cytomegalovirus Latency and Reactivation in Allogeneic Hematopoietic Stem Cell Transplant Recipients","volume":"10","author":"Stern","year":"2019","journal-title":"Front. Microbiol."},{"key":"ref_22","doi-asserted-by":"crossref","unstructured":"Collins-McMillen, D., Buehler, J., Peppenelli, M., and Goodrum, F. (2018). Molecular Determinants and the Regulation of Human Cytomegalovirus Latency and Reactivation. Viruses, 10.","DOI":"10.3390\/v10080444"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1093\/bmb\/ldz031","article-title":"Advances in the treatment of cytomegalovirus","volume":"131","author":"Krishna","year":"2019","journal-title":"Br. Med. Bull."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.jcv.2007.10.027","article-title":"Modulation of natural killer cells by human cytomegalovirus","volume":"41","author":"Wilkinson","year":"2008","journal-title":"J. Clin. Virol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1002\/eji.200425746","article-title":"Ex vivo expansion of human cytomegalovirus-specific cytotoxic T cells by recombinant polyepitope: Implications for HCMV immunotherapy","volume":"35","author":"Rist","year":"2005","journal-title":"Eur. J. Immunol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1016\/j.humimm.2004.02.018","article-title":"Use of a lentiviral vector encoding a HCMV-chimeric IE1-pp65 protein for epitope identification in HLA-Transgenic mice and for ex vivo stimulation and expansion of CD8(+) cytotoxic T cells from human peripheral blood cells","volume":"65","author":"Rohrlich","year":"2004","journal-title":"Hum. Immunol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1006\/viro.1996.0424","article-title":"Recognition of human cytomegalovirus gene products by HCMV-specific cytotoxic T cells","volume":"222","author":"Boppana","year":"1996","journal-title":"Virology"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1084\/jem.20050882","article-title":"Broadly targeted human cytomegalovirus-specific CD4+ and CD8+ T cells dominate the memory compartments of exposed subjects","volume":"202","author":"Sylwester","year":"2005","journal-title":"J. Exp. Med."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"4077","DOI":"10.1172\/JCI42758","article-title":"Molecular profiling of cytomegalovirus-induced human CD8+ T cell differentiation","volume":"120","author":"Hertoghs","year":"2010","journal-title":"J. Clin. Invest."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"8140","DOI":"10.1128\/JVI.74.17.8140-8150.2000","article-title":"Functional heterogeneity and high frequencies of cytomegalovirus-specific CD8(+) T lymphocytes in healthy seropositive donors","volume":"74","author":"Gillespie","year":"2000","journal-title":"J. Virol."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"1834","DOI":"10.4049\/jimmunol.173.3.1834","article-title":"Emergence of a CD4+CD28- granzyme B+, cytomegalovirus-specific T cell subset after recovery of primary cytomegalovirus infection","volume":"173","author":"Remmerswaal","year":"2004","journal-title":"J. Immunol."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"1676","DOI":"10.1002\/1521-4141(200006)30:6<1676::AID-IMMU1676>3.0.CO;2-V","article-title":"Analysis of CD8 T cell reactivity to cytomegalovirus using protein-spanning pools of overlapping pentadecapeptides","volume":"30","author":"Kern","year":"2000","journal-title":"Eur. J. Immunol."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"1620","DOI":"10.1002\/jmv.25225","article-title":"Human cytomegalovirus (HCMV)-specific T cell but not neutralizing or IgG binding antibody responses to glycoprotein complexes gB, gHgLgO, and pUL128L correlate with protection against high HCMV viral load reactivation in solid-organ transplant recipients","volume":"90","author":"Lilleri","year":"2018","journal-title":"J. Med. Virol."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1093\/infdis\/166.3.473","article-title":"Phase I-II trial of foscarnet for prevention of cytomegalovirus infection in autologous and allogeneic marrow transplant recipients","volume":"166","author":"Reusser","year":"1992","journal-title":"J. Infect. Dis."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1111\/j.1749-6632.1991.tb33450.x","article-title":"Development of a treatment regimen for human cytomegalovirus (CMV) infection in bone marrow transplantation recipients by adoptive transfer of donor-derived CMV-specific T cell clones expanded in vitro","volume":"636","author":"Greenberg","year":"1991","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"1659","DOI":"10.1093\/cid\/cix622","article-title":"Human Cytomegalovirus-Specific Memory CD4+ T-Cell Response and Its Correlation With Virus Transmission to the Fetus in Pregnant Women With Primary Infection","volume":"65","author":"Fornara","year":"2017","journal-title":"Clin. Infect. Dis."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1038\/nri932","article-title":"Antigens and immunoevasins: Opponents in cytomegalovirus immune surveillance","volume":"2","author":"Reddehase","year":"2002","journal-title":"Nat. Rev. Immunol."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"2059","DOI":"10.1099\/0022-1317-72-9-2059","article-title":"Monocytes are a major site of persistence of human cytomegalovirus in peripheral blood mononuclear cells","volume":"72","author":"Sissons","year":"1991","journal-title":"J. Gen. Virol."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"3099","DOI":"10.1099\/0022-1317-77-12-3099","article-title":"Detection of endogenous human cytomegalovirus in CD34+ bone marrow progenitors","volume":"77","author":"Mendelson","year":"1996","journal-title":"J. Gen. Virol."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"20039","DOI":"10.1073\/pnas.1014509107","article-title":"Experimental human cytomegalovirus latency in CD14+ monocytes","volume":"107","author":"Hargett","year":"2010","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1182\/blood-2007-01-070078","article-title":"Human cytomegalovirus sequences expressed in latently infected individuals promote a latent infection in vitro","volume":"110","author":"Goodrum","year":"2007","journal-title":"Blood"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1099\/vir.0.015602-0","article-title":"Analysis of latent viral gene expression in natural and experimental latency models of human cytomegalovirus and its correlation with histone modifications at a latent promoter","volume":"91","author":"Reeves","year":"2010","journal-title":"J. Gen. Virol."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"11879","DOI":"10.1073\/pnas.91.25.11879","article-title":"Human cytomegalovirus latent infection of granulocyte-macrophage progenitors","volume":"91","author":"Kondo","year":"1994","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"11022","DOI":"10.1128\/JVI.79.17.11022-11034.2005","article-title":"Characterization of an antisense transcript spanning the UL81-82 locus of human cytomegalovirus","volume":"79","author":"Bego","year":"2005","journal-title":"J. Virol."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"7465","DOI":"10.1128\/JVI.00088-11","article-title":"Viral interleukin-10 expressed by human cytomegalovirus during the latent phase of infection modulates latently infected myeloid cell differentiation","volume":"85","author":"Avdic","year":"2011","journal-title":"J. Virol."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"4261","DOI":"10.1128\/JVI.03497-12","article-title":"The myeloid transcription factor GATA-2 regulates the viral UL144 gene during human cytomegalovirus latency in an isolate-specific manner","volume":"87","author":"Poole","year":"2013","journal-title":"J. Virol."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"5949","DOI":"10.1128\/JVI.75.13.5949-5957.2001","article-title":"Human cytomegalovirus chemokine receptor gene US28 is transcribed in latently infected THP-1 monocytes","volume":"75","author":"Beisser","year":"2001","journal-title":"J. Virol."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"19755","DOI":"10.1073\/pnas.1115861108","article-title":"High-resolution human cytomegalovirus transcriptome","volume":"108","author":"Gatherer","year":"2011","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_49","doi-asserted-by":"crossref","unstructured":"Mason, G.M., Jackson, S., Okecha, G., Poole, E., Sissons, J.G., Sinclair, J., and Wills, M.R. (2013). Human cytomegalovirus latency-associated proteins elicit immune-suppressive IL-10 producing CD4(+) T cells. PLoS Pathog., 9.","DOI":"10.1371\/journal.ppat.1003635"},{"key":"ref_50","doi-asserted-by":"crossref","unstructured":"Lilleri, D., Kabanova, A., Revello, M.G., Percivalle, E., Sarasini, A., Genini, E., Sallusto, F., Lanzavecchia, A., Corti, D., and Gerna, G. (2013). Fetal human cytomegalovirus transmission correlates with delayed maternal antibodies to gH\/gL\/pUL128-130-131 complex during primary infection. PLoS ONE, 8.","DOI":"10.1371\/journal.pone.0059863"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"17965","DOI":"10.1073\/pnas.1415310111","article-title":"Antibody-driven design of a human cytomegalovirus gHgLpUL128L subunit vaccine that selectively elicits potent neutralizing antibodies","volume":"111","author":"Kabanova","year":"2014","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1128\/JVI.01809-09","article-title":"Isolation of human monoclonal antibodies that potently neutralize human cytomegalovirus infection by targeting different epitopes on the gH\/gL\/UL128-131A complex","volume":"84","author":"Macagno","year":"2010","journal-title":"J. Virol."},{"key":"ref_53","doi-asserted-by":"crossref","unstructured":"Vanarsdall, A.L., Howard, P.W., Wisner, T.W., and Johnson, D.C. (2016). Human Cytomegalovirus gH\/gL Forms a Stable Complex with the Fusion Protein gB in Virions. PLoS Pathog., 12.","DOI":"10.1371\/journal.ppat.1005564"},{"key":"ref_54","doi-asserted-by":"crossref","unstructured":"Bu, W., Joyce, M.G., Nguyen, H., Banh, D.V., Aguilar, F., Tariq, Z., Yap, M.L., Tsujimura, Y., Gillespie, R.A., and Tsybovsky, Y. (2019). Immunization with Components of the Viral Fusion Apparatus Elicits Antibodies That Neutralize Epstein-Barr Virus in B Cells and Epithelial Cells. Immunity.","DOI":"10.1016\/j.immuni.2019.03.010"},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1016\/j.cell.2018.06.028","article-title":"An Unbiased Screen for Human Cytomegalovirus Identifies Neuropilin-2 as a Central Viral Receptor","volume":"174","author":"Marcandalli","year":"2018","journal-title":"Cell"},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.coviro.2018.05.004","article-title":"From recognition to execution-the HCMV Pentamer from receptor binding to fusion triggering","volume":"31","author":"Malito","year":"2018","journal-title":"Curr. Opin. Virol."},{"key":"ref_57","doi-asserted-by":"crossref","unstructured":"Ciferri, C., Chandramouli, S., Leitner, A., Donnarumma, D., Cianfrocco, M.A., Gerrein, R., Friedrich, K., Aggarwal, Y., Palladino, G., and Aebersold, R. (2015). Antigenic Characterization of the HCMV gH\/gL\/gO and Pentamer Cell Entry Complexes Reveals Binding Sites for Potently Neutralizing Human Antibodies. PLoS Pathog., 11.","DOI":"10.1371\/journal.ppat.1005230"},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1128\/JVI.02393-14","article-title":"Identification of a neutralizing epitope within antigenic domain 5 of glycoprotein B of human cytomegalovirus","volume":"89","author":"Wiegers","year":"2015","journal-title":"J. Virol."},{"key":"ref_59","doi-asserted-by":"crossref","unstructured":"Spindler, N., Diestel, U., Stump, J.D., Wiegers, A.K., Winkler, T.H., Sticht, H., Mach, M., and Muller, Y.A. (2014). Structural basis for the recognition of human cytomegalovirus glycoprotein B by a neutralizing human antibody. PLoS Pathog., 10.","DOI":"10.1371\/journal.ppat.1004377"},{"key":"ref_60","doi-asserted-by":"crossref","unstructured":"Potzsch, S., Spindler, N., Wiegers, A.K., Fisch, T., Rucker, P., Sticht, H., Grieb, N., Baroti, T., Weisel, F., and Stamminger, T. (2011). B cell repertoire analysis identifies new antigenic domains on glycoprotein B of human cytomegalovirus which are target of neutralizing antibodies. PLoS Pathog., 7.","DOI":"10.1371\/journal.ppat.1002172"},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"1907","DOI":"10.1093\/infdis\/jiy102","article-title":"Epitope-Specific Humoral Responses to Human Cytomegalovirus Glycoprotein-B Vaccine With MF59: Anti-AD2 Levels Correlate With Protection From Viremia","volume":"217","author":"Baraniak","year":"2018","journal-title":"J. Infect. Dis."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1093\/infdis\/jiz089","article-title":"Original Antigenic Sin Shapes the Immunological Repertoire Evoked by Human Cytomegalovirus Glycoprotein B\/MF59 Vaccine in Seropositive Recipients","volume":"220","author":"Baraniak","year":"2019","journal-title":"J. Infect. Dis."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"10960","DOI":"10.1128\/JVI.78.20.10960-10966.2004","article-title":"Identification of proteins in human cytomegalovirus (HCMV) particles: The HCMV proteome","volume":"78","author":"Varnum","year":"2004","journal-title":"J. Virol."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1126\/science.1227919","article-title":"Decoding human cytomegalovirus","volume":"338","author":"Weisburd","year":"2012","journal-title":"Science"},{"key":"ref_65","doi-asserted-by":"crossref","unstructured":"Nguyen, C.C., and Kamil, J.P. (2018). Pathogen at the Gates: Human Cytomegalovirus Entry and Cell Tropism. Viruses, 10.","DOI":"10.20944\/preprints201811.0378.v2"},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"E9889","DOI":"10.1073\/pnas.1806305115","article-title":"Role of PDGF receptor-alpha during human cytomegalovirus entry into fibroblasts","volume":"115","author":"Wu","year":"2018","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_67","doi-asserted-by":"crossref","unstructured":"Wu, Y., Prager, A., Boos, S., Resch, M., Brizic, I., Mach, M., Wildner, S., Scrivano, L., and Adler, B. (2017). Human cytomegalovirus glycoprotein complex gH\/gL\/gO uses PDGFR-alpha as a key for entry. PLoS Pathog., 13.","DOI":"10.1371\/journal.ppat.1006281"},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"16082","DOI":"10.1038\/nmicrobiol.2016.82","article-title":"Platelet-derived growth factor-alpha receptor is the cellular receptor for human cytomegalovirus gHgLgO trimer","volume":"1","author":"Kabanova","year":"2016","journal-title":"Nat. Microbiol."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"7043","DOI":"10.1073\/pnas.1814850116","article-title":"OR14I1 is a receptor for the human cytomegalovirus pentameric complex and defines viral epithelial cell tropism","volume":"116","author":"E","year":"2019","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_70","doi-asserted-by":"crossref","unstructured":"Ye, X., Gui, X., Freed, D.C., Ku, Z., Li, L., Chen, Y., Xiong, W., Fan, X., Su, H., and He, X. (2019). Identification of adipocyte plasma membrane-associated protein as a novel modulator of human cytomegalovirus infection. PLoS Pathog., 15.","DOI":"10.1371\/journal.ppat.1007914"},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"2699","DOI":"10.1038\/s41467-019-10587-1","article-title":"CD46 facilitates entry and dissemination of human cytomegalovirus","volume":"10","author":"Stein","year":"2019","journal-title":"Nat. Commun."},{"key":"ref_72","doi-asserted-by":"crossref","unstructured":"Vanarsdall, A.L., Pritchard, S.R., Wisner, T.W., Liu, J., Jardetzky, T.S., and Johnson, D.C. (2018). CD147 Promotes Entry of Pentamer-Expressing Human Cytomegalovirus into Epithelial and Endothelial Cells. MBio, 9.","DOI":"10.1128\/mBio.00781-18"},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"18153","DOI":"10.1073\/pnas.0509201102","article-title":"Human cytomegalovirus virion protein complex required for epithelial and endothelial cell tropism","volume":"102","author":"Wang","year":"2005","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"8191","DOI":"10.1128\/JVI.72.10.8191-8197.1998","article-title":"The human cytomegalovirus UL74 gene encodes the third component of the glycoprotein H-glycoprotein L-containing envelope complex","volume":"72","author":"Huber","year":"1998","journal-title":"J. Virol."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"2585","DOI":"10.1128\/JVI.02249-09","article-title":"A human cytomegalovirus gO-null mutant fails to incorporate gH\/gL into the virion envelope and is unable to enter fibroblasts and epithelial and endothelial cells","volume":"84","author":"Wille","year":"2010","journal-title":"J. Virol."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"1767","DOI":"10.1073\/pnas.1424818112","article-title":"Structural and biochemical studies of HCMV gH\/gL\/gO and Pentamer reveal mutually exclusive cell entry complexes","volume":"112","author":"Ciferri","year":"2015","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"8999","DOI":"10.1128\/JVI.01325-15","article-title":"Human Cytomegalovirus gH\/gL\/gO Promotes the Fusion Step of Entry into All Cell Types, whereas gH\/gL\/UL128-131 Broadens Virus Tropism through a Distinct Mechanism","volume":"89","author":"Zhou","year":"2015","journal-title":"J. Virol."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"12014","DOI":"10.1074\/jbc.M116.721746","article-title":"Global Mapping of O-Glycosylation of Varicella Zoster Virus, Human Cytomegalovirus, and Epstein-Barr Virus","volume":"291","author":"Bagdonaite","year":"2016","journal-title":"J. Biol. Chem."},{"key":"ref_79","doi-asserted-by":"crossref","unstructured":"Nogalski, M.T., Chan, G.C., Stevenson, E.V., Collins-McMillen, D.K., and Yurochko, A.D. (2013). The HCMV gH\/gL\/UL128-131 complex triggers the specific cellular activation required for efficient viral internalization into target monocytes. PLoS Pathog., 9.","DOI":"10.1371\/journal.ppat.1003463"},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"7444","DOI":"10.1128\/JVI.00467-12","article-title":"Antibodies against the gH\/gL\/UL128\/UL130\/UL131 complex comprise the majority of the anti-cytomegalovirus (anti-CMV) neutralizing antibody response in CMV hyperimmune globulin","volume":"86","author":"Fouts","year":"2012","journal-title":"J. Virol."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.3390\/v6031346","article-title":"HCMV infection of human trophoblast progenitor cells of the placenta is neutralized by a human monoclonal antibody to glycoprotein B and not by antibodies to the pentamer complex","volume":"6","author":"Zydek","year":"2014","journal-title":"Viruses"},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"e00332-13","DOI":"10.1128\/mBio.00332-13","article-title":"Human cytomegalovirus (HCMV) glycoprotein gB promotes virus entry in trans acting as the viral fusion protein rather than as a receptor-binding protein","volume":"4","author":"Wille","year":"2013","journal-title":"MBio"},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"16","DOI":"10.4161\/hv.1.1.1335","article-title":"A DNA-based vaccine for the prevention of human cytomegalovirus-associated diseases","volume":"1","author":"Selinsky","year":"2005","journal-title":"Hum. Vaccin."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1099\/vir.0.81516-0","article-title":"Characterization and immunological analysis of the rhesus cytomegalovirus homologue (Rh112) of the human cytomegalovirus UL83 lower matrix phosphoprotein (pp65)","volume":"87","author":"Yue","year":"2006","journal-title":"J. Gen. Virol."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1038\/nri2868","article-title":"Vaccine delivery: A matter of size, geometry, kinetics and molecular patterns","volume":"10","author":"Bachmann","year":"2010","journal-title":"Nat. Reviews. Immunol."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.csbj.2015.11.001","article-title":"Self-assembling protein nanoparticles in the design of vaccines","volume":"14","author":"Malito","year":"2016","journal-title":"Comput Struct Biotechnol J."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1002\/eji.200737984","article-title":"Nanoparticles target distinct dendritic cell populations according to their size","volume":"38","author":"Manolova","year":"2008","journal-title":"Eur. J. Immunol."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.immuni.2018.07.005","article-title":"Glycan Masking Focuses Immune Responses to the HIV-1 CD4-Binding Site and Enhances Elicitation of VRC01-Class Precursor Antibodies","volume":"49","author":"Duan","year":"2018","journal-title":"Immunity"},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1016\/j.cell.2015.07.043","article-title":"Rational Design of an Epstein-Barr Virus Vaccine Targeting the Receptor-Binding Site","volume":"162","author":"Kanekiyo","year":"2015","journal-title":"Cell"},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1128\/CVI.00662-13","article-title":"Enveloped virus-like particle expression of human cytomegalovirus glycoprotein B antigen induces antibodies with potent and broad neutralizing activity","volume":"21","author":"Kirchmeier","year":"2014","journal-title":"Clin. Vaccine Immunol. Cvi."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"2673","DOI":"10.1080\/21645515.2019.1593729","article-title":"Development of novel vaccines against human cytomegalovirus","volume":"15","author":"Cui","year":"2019","journal-title":"Hum. Vaccines Immunother."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1002\/elsc.201300093","article-title":"Fully aseptic single-use cross flow filtration system for clarification and concentration of cytomegalovirus-like particles","volume":"14","author":"Vicente","year":"2014","journal-title":"Eng. Life Sci."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1016\/0092-8674(94)90142-2","article-title":"Three-dimensional structure of hepatitis B virus core particles determined by electron cryomicroscopy","volume":"77","author":"Crowther","year":"1994","journal-title":"Cell"},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"15821","DOI":"10.1073\/pnas.0504874102","article-title":"A structural model for maturation of the hepatitis B virus core","volume":"102","author":"Roseman","year":"2005","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"33508","DOI":"10.1074\/jbc.M805211200","article-title":"Internal core protein cleavage leaves the hepatitis B virus capsid intact and enhances its capacity for surface display of heterologous whole chain proteins","volume":"283","author":"Walker","year":"2008","journal-title":"J. Biol. Chem."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1002\/eji.200425755","article-title":"Efficient homologous prime-boost strategies for T cell vaccination based on virus-like particles","volume":"35","author":"Schwarz","year":"2005","journal-title":"Eur. J. Immunol."},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"1755","DOI":"10.1073\/pnas.1816933116","article-title":"Human cytomegalovirus G protein-coupled receptor US28 promotes latency by attenuating c-fos","volume":"116","author":"Krishna","year":"2019","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_98","doi-asserted-by":"crossref","unstructured":"Krishna, B.A., Miller, W.E., and O\u2019Connor, C.M. (2018). US28: HCMV\u2019s Swiss Army Knife. Viruses, 10.","DOI":"10.3390\/v10080445"},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"7457","DOI":"10.1073\/pnas.85.20.7457","article-title":"Redox reactivity of bacterial and mammalian ferritin: Is reductant entry into the ferritin interior a necessary step for iron release?","volume":"85","author":"Watt","year":"1988","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1146\/annurev.bi.56.070187.001445","article-title":"Ferritin: Structure, gene regulation, and cellular function in animals, plants, and microorganisms","volume":"56","author":"Theil","year":"1987","journal-title":"Annu. Rev. Biochem."},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.jmb.2009.04.078","article-title":"The crystal structure of ferritin from Helicobacter pylori reveals unusual conformational changes for iron uptake","volume":"390","author":"Cho","year":"2009","journal-title":"J. Mol. Biol."},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"3596","DOI":"10.1021\/acs.biochem.7b00296","article-title":"Thermophilic Ferritin 24mer Assembly and Nanoparticle Encapsulation Modulated by Interdimer Electrostatic Repulsion","volume":"56","author":"Pulsipher","year":"2017","journal-title":"Biochemistry"},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1021\/acsinfecdis.7b00192","article-title":"Two-Component Ferritin Nanoparticles for Multimerization of Diverse Trimeric Antigens","volume":"4","author":"Georgiev","year":"2018","journal-title":"Acs. Infect. Dis."},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1038\/s41590-018-0305-x","article-title":"Mosaic nanoparticle display of diverse influenza virus hemagglutinins elicits broad B cell responses","volume":"20","author":"Kanekiyo","year":"2019","journal-title":"Nat. Immunol."},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/S0969-2126(96)00060-3","article-title":"The crystal structure of bacteriophage Q beta at 3.5 A resolution","volume":"4","author":"Golmohammadi","year":"1996","journal-title":"Structure"},{"key":"ref_106","doi-asserted-by":"crossref","unstructured":"Cornuz, J., Zwahlen, S., Jungi, W.F., Osterwalder, J., Klingler, K., van Melle, G., Bangala, Y., Guessous, I., Muller, P., and Willers, J. (2008). A vaccine against nicotine for smoking cessation: A randomized controlled trial. PLoS ONE, 3.","DOI":"10.1371\/journal.pone.0002547"},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/S0014-5793(98)00716-9","article-title":"Mosaic Qbeta coats as a new presentation model","volume":"431","author":"Vasiljeva","year":"1998","journal-title":"Febs. Lett."},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1038\/nature20108","article-title":"Corrigendum: Design of a hyperstable 60-subunit protein icosahedron","volume":"540","author":"Hsia","year":"2016","journal-title":"Nature"},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1038\/nature13404","article-title":"Accurate design of co-assembling multi-component protein nanomaterials","volume":"510","author":"King","year":"2014","journal-title":"Nature"},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1126\/science.aaf8818","article-title":"Accurate design of megadalton-scale two-component icosahedral protein complexes","volume":"353","author":"Bale","year":"2016","journal-title":"Science"},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"eaau6769","DOI":"10.1126\/sciadv.aau6769","article-title":"HIV-1 vaccine design through minimizing envelope metastability","volume":"4","author":"He","year":"2018","journal-title":"Sci. Adv."},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.1016\/j.cell.2019.01.046","article-title":"Induction of Potent Neutralizing Antibody Responses by a Designed Protein Nanoparticle Vaccine for Respiratory Syncytial Virus","volume":"176","author":"Marcandalli","year":"2019","journal-title":"Cell"},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"4272","DOI":"10.1038\/s41467-019-12080-1","article-title":"Enhancing and shaping the immunogenicity of native-like HIV-1 envelope trimers with a two-component protein nanoparticle","volume":"10","author":"Brouwer","year":"2019","journal-title":"Nat. Commun."},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1126\/science.aav7897","article-title":"De novo design of tunable, pH-driven conformational changes","volume":"364","author":"Boyken","year":"2019","journal-title":"Science"},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1038\/nature20607","article-title":"Designed proteins induce the formation of nanocage-containing extracellular vesicles","volume":"540","author":"Votteler","year":"2016","journal-title":"Nature"},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"E690","DOI":"10.1073\/pnas.1115485109","article-title":"Peptide tag forming a rapid covalent bond to a protein, through engineering a bacterial adhesin","volume":"109","author":"Zakeri","year":"2012","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"19234","DOI":"10.1038\/srep19234","article-title":"Plug-and-Display: Decoration of Virus-Like Particles via isopeptide bonds for modular immunization","volume":"6","author":"Brune","year":"2016","journal-title":"Sci. Rep."},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"e1408749","DOI":"10.1080\/2162402X.2017.1408749","article-title":"Virus-like particle display of HER2 induces potent anti-cancer responses","volume":"7","author":"Palladini","year":"2018","journal-title":"Oncoimmunology"},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/s12951-016-0181-1","article-title":"Bacterial superglue enables easy development of efficient virus-like particle based vaccines","volume":"14","author":"Thrane","year":"2016","journal-title":"J. Nanobiotechnology"},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.immuni.2017.11.023","article-title":"Precursor Frequency and Affinity Determine B Cell Competitive Fitness in Germinal Centers, Tested with Germline-Targeting HIV Vaccine Immunogens","volume":"48","author":"Abbott","year":"2018","journal-title":"Immunity"},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"12041","DOI":"10.1038\/ncomms12041","article-title":"Presenting native-like trimeric HIV-1 antigens with self-assembling nanoparticles","volume":"7","author":"He","year":"2016","journal-title":"Nat. Commun."},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"10618","DOI":"10.1038\/ncomms10618","article-title":"Specifically modified Env immunogens activate B-cell precursors of broadly neutralizing HIV-1 antibodies in transgenic mice","volume":"7","author":"McGuire","year":"2016","journal-title":"Nat. Commun."},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1186\/s12977-015-0210-4","article-title":"Presenting native-like HIV-1 envelope trimers on ferritin nanoparticles improves their immunogenicity","volume":"12","author":"Sliepen","year":"2015","journal-title":"Retrovirology"}],"container-title":["Viruses"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1999-4915\/12\/1\/35\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T13:46:25Z","timestamp":1760190385000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1999-4915\/12\/1\/35"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,12,28]]},"references-count":123,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2020,1]]}},"alternative-id":["v12010035"],"URL":"https:\/\/doi.org\/10.3390\/v12010035","relation":{},"ISSN":["1999-4915"],"issn-type":[{"value":"1999-4915","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,12,28]]}}}